| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. | Leukemia | 2012 | 1.74 |
| 2 | The use of novel agents in the treatment of relapsed and refractory multiple myeloma. | Leukemia | 2009 | 1.30 |
| 3 | Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation. | Bone Marrow Transplant | 2009 | 0.90 |
| 4 | Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy. | Leukemia | 2013 | 0.84 |
| 5 | Second primary malignancies in multiple myeloma: an overview and IMWG consensus. | Ann Oncol | 2017 | 0.75 |